Cargando…
MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells
Glioma is the most common malignant tumor of the central nervous system with poor survival. Temozolomide (TMZ) is the first-line chemotherapy drug for initial and recurrent glioma treatment with a relatively good efficacy, which exerts its antitumor effects mainly through cell death induced by DNA d...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287895/ https://www.ncbi.nlm.nih.gov/pubmed/30273182 http://dx.doi.org/10.1097/CAD.0000000000000700 |